rs2395083

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365276.2(TNXB):​c.11530+46C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00356 in 1,613,126 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 1 hom., cov: 27)
Exomes 𝑓: 0.0036 ( 11 hom. )

Consequence

TNXB
NM_001365276.2 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.74

Publications

0 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 6-32043703-G-A is Benign according to our data. Variant chr6-32043703-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 261110.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.00362 (5283/1461056) while in subpopulation SAS AF = 0.0118 (1021/86228). AF 95% confidence interval is 0.0112. There are 11 homozygotes in GnomAdExome4. There are 2733 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 11 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365276.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
NM_001365276.2
MANE Select
c.11530+46C>T
intron
N/ANP_001352205.1
TNXB
NM_001428335.1
c.12271+46C>T
intron
N/ANP_001415264.1
TNXB
NM_019105.8
c.11524+46C>T
intron
N/ANP_061978.6

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
ENST00000644971.2
MANE Select
c.11530+46C>T
intron
N/AENSP00000496448.1
TNXB
ENST00000451343.4
TSL:1
c.817+46C>T
intron
N/AENSP00000407685.1
TNXB
ENST00000490077.5
TSL:1
n.1357+46C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00305
AC:
463
AN:
151952
Hom.:
1
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.00138
Gnomad AMI
AF:
0.0780
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.00851
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00363
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00325
AC:
813
AN:
250172
AF XY:
0.00366
show subpopulations
Gnomad AFR exome
AF:
0.00162
Gnomad AMR exome
AF:
0.00150
Gnomad ASJ exome
AF:
0.000299
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.000465
Gnomad NFE exome
AF:
0.00311
Gnomad OTH exome
AF:
0.00457
GnomAD4 exome
AF:
0.00362
AC:
5283
AN:
1461056
Hom.:
11
Cov.:
32
AF XY:
0.00376
AC XY:
2733
AN XY:
726854
show subpopulations
African (AFR)
AF:
0.00173
AC:
58
AN:
33480
American (AMR)
AF:
0.00168
AC:
75
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26134
East Asian (EAS)
AF:
0.000302
AC:
12
AN:
39700
South Asian (SAS)
AF:
0.0118
AC:
1021
AN:
86228
European-Finnish (FIN)
AF:
0.000683
AC:
36
AN:
52708
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5768
European-Non Finnish (NFE)
AF:
0.00347
AC:
3857
AN:
1111932
Other (OTH)
AF:
0.00336
AC:
203
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
261
521
782
1042
1303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00304
AC:
462
AN:
152070
Hom.:
1
Cov.:
27
AF XY:
0.00280
AC XY:
208
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00138
AC:
57
AN:
41446
American (AMR)
AF:
0.00216
AC:
33
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5168
South Asian (SAS)
AF:
0.00831
AC:
40
AN:
4812
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00363
AC:
247
AN:
67986
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00323
Hom.:
1
Bravo
AF:
0.00323
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Sep 26, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.60
DANN
Benign
0.83
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2395083; hg19: chr6-32011480; API